首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1460166

自体输血设备市场 - 按产品、应用、最终用途 - 全球预测，2024 年 - 2032 年

Autotransfusion Devices Market - By Product, Application, End-use - Global Forecast, 2024 - 2032

出版日期: 2024年02月26日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在手术数量不断增加和新产品不断开发的推动下，自体输血设备市场规模预计在 2024 年至 2032 年间以 6.2% 的CAGR扩大。

随着全球外科手术数量的不断增加，特别是在骨科、心臟和创伤手术中，对自体输血设备的需求正在显着增加。不断进步的技术推动了创新自体输血设备的开发，这些设备具有改进的功能，例如增强的过滤系统、紧凑的设计和用户友好的介面。例如，2024 年 2 月，ProCell Surgical 的海绵血回收装置获得了 CE 标誌许可，这是一种改进医院术中自体输血 (IAT) 系统的专利设备。

最近，医疗保健系统也分配资金用于改善手术结果和减少输血相关併发症。据印度国家卫生医院联合会称，医疗保健部门主张将医疗保健支出增加至 GDP 的 2.5%。此外，对病患安全和资源高效利用的日益关注将进一步推动市场成长。

自体输血设备产业分为产品、应用、最终用途和地区。

从产品来看，2024年至2032年消耗品及配件领域的市场规模预计将达到5.9%的成长率。最近，采血袋、过滤器、管道装置和抽吸罐在自体输血过程中发挥着至关重要的作用。需要输血的手术数量不断增加，加上自体输血技术的进步，增加了对高品质耗材和配件的需求。医院和外科中心依靠这些产品在手术过程中实现高效、安全的血液回收和回输。此外，对减少输血相关併发症和改善患者治疗结果的高度重视进一步推动了先进耗材的采用。

在应用方面，骨科手术领域的自体输血设备产业在2023年产生了可观的收入，预计2024年至2032年的CAGR为6.6%。骨科手术，如关节置换和脊椎手术，由于输血的原因，通常需要输血。严重失血的可能性。自体输血装置对于收集、过滤和回输患者的血液至关重要，同时减少同种异体输血的需求和相关风险。由于人口老化和运动伤害的增加，对骨科手术的需求不断增长，对高效血液管理解决方案的需求预计将保持稳定。

从地区来看，由于慢性病盛行率上升、手术数量增加以及医疗基础设施改善，亚太地区自体输血设备产业预计在 2024 年至 2032 年期间CAGR为 7.1%。中国、印度和日本等国的骨科、心臟和创伤手术激增，对自体输血设备产生了巨大的需求。此外，人口老化以及人们对血液安全和输血风险的认识不断增强，正在推动区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 外科手术数量不断增加
  - 自体输血装置的技术进步
  - 对微创外科手术的需求不断增长
- 产业陷阱与挑战
  - 自体输血系统相关的高成本
  - 併发症和感染的风险
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析
报销场景
未来市场趋势
缺口分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

主要趋势
自体输血系统
- 术中自体输血系统
- 术后自体输血系统
- 双模式自体输血系统
耗材及配件

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

主要趋势
心血管手术
骨科手术
器官移植
一般外科
其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

主要趋势
医院
门诊手术中心
其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Atrium Medical Corporation
Becton, Dickinson and Company
Beijing ZKSK Technology Co., Ltd.
Braile Biomédica
Fresenius SE & Co. KGaA
Gen World Medical Devices
Haemonetics Corporation
LivaNova, Inc.
Medtronic plc
Redax
Teleflex Incorporated

简介目录

Product Code: 8266

Autotransfusion Devices Market size is poised to expand at 6.2% CAGR between 2024 and 2032, propelled by the rising number of surgeries and continuous new product developments.

With the growing number of surgical procedures globally, particularly in orthopedics, cardiac, and trauma surgeries, the demand for autotransfusion devices is significantly rising. Rising technology advancements are leading to the development of innovative autotransfusion devices with improved features, such as enhanced filtration systems, compact designs, and user-friendly interfaces. For instance, in February 2024, ProCell Surgical received CE-marked clearance for its Sponge Blood Recovery Unit, a patented device that improves intraoperative autotransfusion (IAT) systems in hospitals.

Of late, healthcare systems are also allocating funds towards improving surgical outcomes and reducing transfusion-related complications. According to the National Health-Hospital Federation of India, the healthcare sector is advocating for an increase in healthcare expenditures to 2.5% of GDP. Moreover, the growing focus on patient safety and efficient resource utilization will further boost the market growth.

The autotransfusion devices industry is segmented into product, application, end-use, and region.

Based on product, the market size from the consumables & accessories segment is projected to record 5.9% growth rate from 2024-2032. Of late, blood collection bags, filters, tubing sets, and suction canisters are playing a crucial role in autotransfusion procedures. The rising number of surgeries requiring blood transfusions coupled with advancements in autotransfusion technology are boosting the demand for high-quality consumables and accessories. Hospitals and surgical centers rely on these products for efficient and safe blood recovery and reinfusion during procedures. Additionally, the strong emphasis on reducing transfusion-related complications and improving patient outcomes is further propelling the adoption of advanced consumables.

In terms of application, the autotransfusion devices industry from the orthopedic surgeries segment generated considerable revenue in 2023 and is estimated to witness 6.6% CAGR between 2024 and 2032. Orthopedic surgeries, such as joint replacements and spinal procedures, often require blood transfusions due to the potential for significant blood loss. Autotransfusion devices are essential in collecting, filtering, and reinfusing a patient's blood while reducing the need for allogeneic transfusions and associated risks. With the rising demand for orthopedic procedures due to an aging population and increasing sports injuries, the need for efficient blood management solutions is expected to remain steady.

Regionally, the Asia Pacific autotransfusion devices industry is set to exhibit 7.1% CAGR during 2024-2032 owing to the rising prevalence of chronic diseases, increasing number of surgeries, and improving healthcare infrastructure. Countries, such as China, India, and Japan are witnessing a surge in orthopedic, cardiac, and trauma surgeries, creating a substantial demand for autotransfusion devices. Additionally, the presence of an aging population and growing awareness about blood safety and transfusion risks are fueling the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising number in surgical procedures
  - 3.2.1.2 Technological advancements in autotransfusion devices
  - 3.2.1.3 Growing demand for minimally invasive surgical procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with autotransfusion systems
  - 3.2.2.2 Risk of complications and infections
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Autotransfusion systems
- 5.2.1 Intraoperative autotransfusion systems
- 5.2.2 Post-operative autotransfusion systems
- 5.2.3 Dual-mode autotransfusion systems
5.3 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Cardiovascular surgeries
6.3 Orthopedic surgeries
6.4 Organ transplantation
6.5 General surgery
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa